124 related articles for article (PubMed ID: 37914328)
21. Transcriptional Repression and Protein Degradation of the Ca
Khatun A; Shimozawa M; Kito H; Kawaguchi M; Fujimoto M; Ri M; Kajikuri J; Niwa S; Fujii M; Ohya S
Front Physiol; 2018; 9():312. PubMed ID: 29713287
[TBL] [Abstract][Full Text] [Related]
22. Modeling interactions between voltage-gated Ca (2+) channels and KCa1.1 channels.
Engbers JD; Zamponi GW; Turner RW
Channels (Austin); 2013; 7(6):524-9. PubMed ID: 23928916
[TBL] [Abstract][Full Text] [Related]
23. Erectile Dysfunction and Altered Contribution of KCa1.1 and KCa2.3 Channels in the Penile Tissue of Type-2 Diabetic db/db Mice.
Comerma-Steffensen S; Prat-Duran J; Mogensen S; Fais R; Pinilla E; Simonsen U
J Sex Med; 2022 May; 19(5):697-710. PubMed ID: 35321830
[TBL] [Abstract][Full Text] [Related]
24. Expression of Ca2+ -activated K+ channels in human dermal fibroblasts and their roles in apoptosis.
Yun J; Park H; Ko JH; Lee W; Kim K; Kim T; Shin J; Kim K; Kim K; Song JH; Noh YH; Bang H; Lim I
Skin Pharmacol Physiol; 2010; 23(2):91-104. PubMed ID: 20016251
[TBL] [Abstract][Full Text] [Related]
25. Characterization of ion channels in human preadipocytes.
Hu H; He ML; Tao R; Sun HY; Hu R; Zang WJ; Yuan BX; Lau CP; Tse HF; Li GR
J Cell Physiol; 2009 Feb; 218(2):427-35. PubMed ID: 18942098
[TBL] [Abstract][Full Text] [Related]
26. Targeting KCa1.1 Channels with a Scorpion Venom Peptide for the Therapy of Rat Models of Rheumatoid Arthritis.
Tanner MR; Pennington MW; Chamberlain BH; Huq R; Gehrmann EJ; Laragione T; Gulko PS; Beeton C
J Pharmacol Exp Ther; 2018 May; 365(2):227-236. PubMed ID: 29453198
[TBL] [Abstract][Full Text] [Related]
27. Functional KCa1.1 channels are crucial for regulating the proliferation, migration and differentiation of human primary skeletal myoblasts.
Tajhya RB; Hu X; Tanner MR; Huq R; Kongchan N; Neilson JR; Rodney GG; Horrigan FT; Timchenko LT; Beeton C
Cell Death Dis; 2016 Oct; 7(10):e2426. PubMed ID: 27763639
[TBL] [Abstract][Full Text] [Related]
28. Role of KCNMA1 in breast cancer.
Oeggerli M; Tian Y; Ruiz C; Wijker B; Sauter G; Obermann E; Güth U; Zlobec I; Sausbier M; Kunzelmann K; Bubendorf L
PLoS One; 2012; 7(8):e41664. PubMed ID: 22899999
[TBL] [Abstract][Full Text] [Related]
29. KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer.
Bloch M; Ousingsawat J; Simon R; Schraml P; Gasser TC; Mihatsch MJ; Kunzelmann K; Bubendorf L
Oncogene; 2007 Apr; 26(17):2525-34. PubMed ID: 17146446
[TBL] [Abstract][Full Text] [Related]
30. Different expression of β subunits of the KCa1.1 channel by invasive and non-invasive human fibroblast-like synoviocytes.
Pethő Z; Tanner MR; Tajhya RB; Huq R; Laragione T; Panyi G; Gulko PS; Beeton C
Arthritis Res Ther; 2016 May; 18(1):103. PubMed ID: 27165430
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and characterisation of NS13558: a new important tool for addressing KCa1.1 channel function ex vivo.
Bentzen BH; Andersen RW; Olesen SP; Grunnet M; Nardi A
Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):271-83. PubMed ID: 19798481
[TBL] [Abstract][Full Text] [Related]
32. KCa1.1 inhibition attenuates fibroblast-like synoviocyte invasiveness and ameliorates disease in rat models of rheumatoid arthritis.
Tanner MR; Hu X; Huq R; Tajhya RB; Sun L; Khan FS; Laragione T; Horrigan FT; Gulko PS; Beeton C
Arthritis Rheumatol; 2015 Jan; 67(1):96-106. PubMed ID: 25252152
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and pharmacological evaluation of ester-based quercetin derivatives as selective vascular K
Carullo G; Ahmed A; Trezza A; Spiga O; Brizzi A; Saponara S; Fusi F; Aiello F
Bioorg Chem; 2020 Dec; 105():104404. PubMed ID: 33142229
[TBL] [Abstract][Full Text] [Related]
34. KCa1.1 channel contributes to cell excitability in unmyelinated but not myelinated rat vagal afferents.
Li BY; Glazebrook P; Kunze DL; Schild JH
Am J Physiol Cell Physiol; 2011 Jun; 300(6):C1393-403. PubMed ID: 21325638
[TBL] [Abstract][Full Text] [Related]
35. The secretory KCa1.1 channel localises to crypts of distal mouse colon: functional and molecular evidence.
Sørensen MV; Strandsby AB; Larsen CK; Praetorius HA; Leipziger J
Pflugers Arch; 2011 Nov; 462(5):745-52. PubMed ID: 21822598
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel subunit alpha-1 and calcium channel, voltage-dependent, L type, alpha 1C subunit.
Sánchez-Pastor E; Andrade F; Sánchez-Pastor JM; Elizalde A; Huerta M; Virgen-Ortiz A; Trujillo X; Rodríguez-Hernández A
Eur J Pharmacol; 2014 Apr; 729():100-6. PubMed ID: 24561046
[TBL] [Abstract][Full Text] [Related]
37. A multitarget semi-synthetic derivative of the flavonoid morin with improved in vitro vasorelaxant activity: Role of Ca
Carullo G; Ahmed A; Trezza A; Spiga O; Brizzi A; Saponara S; Fusi F; Aiello F
Biochem Pharmacol; 2021 Mar; 185():114429. PubMed ID: 33513341
[TBL] [Abstract][Full Text] [Related]
38. Caveolae facilitate TRPV4-mediated Ca
Li Y; Hu H; O'Neil RG
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1626-F1636. PubMed ID: 30207167
[TBL] [Abstract][Full Text] [Related]
39. Stimulatory actions of a novel thiourea derivative on large-conductance, calcium-activated potassium channels.
Wu SN; Chern JH; Shen S; Chen HH; Hsu YT; Lee CC; Chan MH; Lai MC; Shie FS
J Cell Physiol; 2017 Dec; 232(12):3409-3421. PubMed ID: 28075010
[TBL] [Abstract][Full Text] [Related]
40. Dynamic coupling between TRPV4 and Ca
Li Y; Hu H; Tian JB; Zhu MX; O'Neil RG
Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1081-F1089. PubMed ID: 28274924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
